Emily and I are headed to san Diego next! #ActivateTheCure #Survivor #CancerImmunotherapy
To celebrate #NationalCancerSurvivorsDay, DIA honors those who have triumphed over cancer, including Emily Whitehead (Emily Whitehead Foundation). Diagnosed with acute lymphoblastic #leukemia (ALL) at just 5 years old, Emily faced overwhelming odds when standard treatments failed to cure her disease. After bravely enrolling in a #clinicaltrial, Emily went on to become the first pediatric patient in the world to receive chimeric antigen receptor (CAR) #Tcell therapy and has been cancer-free for more than a decade. Emily’s powerful story is one of the reasons why we’ve chosen her and her father, Tom Whitehead, to serve as keynote speakers at #DIA2024 later this month and share their journey with T-cell therapy. Learn more: https://lnkd.in/gZry6Nkq
An incredible inspiration to all drug developers Hats off to Carl June, Stephan Grupp & U Penn team for developing CARs & the decision to treat with Tociluzumab at the right time
Fantastic does not begin to describe this.
Heading to BIO!
fantastic!
Linkedin Top Voice| Life Science Lawyer | Board Member | Entrepreneur | Educator, Author, and Speaker
3moIts going to be a great talk!!